Azimuth Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
Azimuth Capital Management's NVO Position: Q4 2016 in Review
Azimuth Capital Management sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 77,720 shares — an estimated $1.62M sold.
Azimuth Capital Management first reported a position in NVO in Q2 2013 and held it in 14 quarters. The position peaked at $5.02M in Q4 2015. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.
- Azimuth Capital Management reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
- Azimuth Capital Management sold 77,720 Novo Nordisk shares in Q4 2016, an estimated $1.62M.
- Azimuth Capital Management first reported a position in Novo Nordisk in Q2 2013 and held it in 14 quarters.
- Azimuth Capital Management's Novo Nordisk position peaked at $5.02M in Q4 2015.
- 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.
Based on Azimuth Capital Management's 13F filing for Q4 2016, filed 13 Feb 2017.